Clinical efficacy of tezepelumab in pre-selected non-type 2 asthma patients.

Chin-See-Chong, T C Timothy; Valk, J P M Johanna van der; Layhadi, J A Janice; Shamji, M H Mohamed; Kappen, J H Jasper

Chin-See-Chong, T C Timothy; Valk, J P M Johanna van der; Layhadi, J A Janice; Shamji, M H Mohamed; Kappen, J H Jasper.

Afiliação

Chin-See-Chong TCT; Department of Pulmonary Diseases, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
Valk JPMJV; Department of Pulmonary Diseases, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
Layhadi JAJ; Department of Pulmonary Diseases, Erasmus Medical Centrum, Rotterdam, The Netherlands.
Shamji MHM; National Heart and Lung Institute, Imperial College London, London, UK.
Kappen JHJ; Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK.

Allergy ; 79(10): 2867-2870, 2024 Oct.

Article em En | MEDLINE | ID: mdl-39034850

Assuntos

Antiasmáticos; Anticorpos Monoclonais Humanizados; Asma; Humanos; Asma/tratamento farmacológico; Anticorpos Monoclonais Humanizados/uso terapêutico; Antiasmáticos/uso terapêutico; Resultado do Tratamento; Feminino; Masculino; Pessoa de Meia-Idade; Adulto

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Anticorpos Monoclonais Humanizados Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Allergy Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google